Arabinoxylans and gelled arabinoxylans used as anti-obesogenic agents could protect the stability of intestinal microbiota of rats consuming high-fat diets

References

• Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data. In Bioinf B, editor. FastQC: a quality control tool for high throughput sequence data. Babraham (CA): Babraham Institute.http://www.bioinformatics.babraham.ac.uk/projects/fastqc.
   Google Scholar
• Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. 2016. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 15:108.
   Google Scholar
• Broekaert WF, Courtin CM, Verbeke K, Van De Wiele T, Verstraete W, Delcour JA. 2011. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr. 51(2):178–194.
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 15(13):1546–1558.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 7(5):335–336.
   PubMed Web of Science ®Google Scholar
• Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell. 148(6):1258–1270.
   PubMed Web of Science ®Google Scholar
• De La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 299(2):G440–G448.
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 7(11):639–646.
   PubMed Web of Science ®Google Scholar
• Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 27(16):2194–2200.
   PubMed Web of Science ®Google Scholar
• Figueroa-Espinoza M, Rouau X. 1998. Oxidative cross-linking of pentosans by a fungal laccase and horseradish peroxidase: mechanism of linkage between feruloylated arabinoxylans. Cereal Chem. 75(2):259–265.
   Web of Science ®Google Scholar
• Foster JA, Neufeld KA. 2013. Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36(5):305–312.
   PubMed Web of Science ®Google Scholar
• Gori A, Rizzardini G, van’t Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C, Bandera A, Knol J, et al. 2011. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial. Mucosal Immunol. 4(5):554.
   PubMed Web of Science ®Google Scholar
• Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Ciulla D, Tabbaa D, Highlander SK, Sodergren E, et al. 2011. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21(3):494–504.
   PubMed Web of Science ®Google Scholar
• Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. 2011. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA. 108(7):3047–3052.
   PubMed Web of Science ®Google Scholar
• Holowacz S, Guigné C, Chêne G, Mouysset S, Guilbot A, Seyrig C, Dubourdeau M. 2015. A multispecies Lactobacillus-and Bifidobacterium-containing probiotic mixture attenuates body weight gain and insulin resistance after a short-term challenge with a high-fat diet in C57/BL6J mice. PharmaNutrition. 3(3):101–107.
   Google Scholar
• Hopkins MJ, Englyst HN, Macfarlane S, Furrie E, Macfarlane GT, Mcbain AJ. 2003. Degradation of cross-linked and non-cross-linked arabinoxylans by the intestinal microbiota in children. Appl Env Microbiol. 69(11):6354–6360.
   PubMed Web of Science ®Google Scholar
• Horz HP, Conrads G. 2010. The discussion goes on: what is the role of Euryarchaeota in humans? Archaea. 2010:967271.
   PubMed Web of Science ®Google Scholar
• Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. 2015. Role of the normal gut microbiota. World J Gastroenterol. 21(29):8787–8803.
   PubMed Web of Science ®Google Scholar
• Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, et al. 2015. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biolo Blood Marrow Transpl. 21(8):1373–1383.
   PubMed Web of Science ®Google Scholar
• Kim KA, Gu W, Lee IA, Joh EH, Kim DH. 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 7(10):e47713.
   PubMed Web of Science ®Google Scholar
• Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, Glöckner FO. 2013. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41(1):e1.
   PubMed Web of Science ®Google Scholar
• Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 31(9):814–821.
   PubMed Web of Science ®Google Scholar
• Maha AH, Haneen HM. 2017. The effect of pomegranate leaves powder on biological, biochemical and histological changes of induced obese rats. J Am Sci. 13:62–70.
   Google Scholar
• Marques TM, Wall R, Ross RP, Fitzgerald GF, Ryan CA, Stanton C. 2010. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol. 21(2):149–156.
   PubMed Web of Science ®Google Scholar
• Mendez-Encinas MA, Carvajal-Millan E, Rascon-Chu A, Astiazaran-Garcia HF, Valencia-Rivera DE. 2018. Ferulated arabinoxylans and their gels: functional properties and potential application as antioxidant and anticancer agent. Oxid Med Cell Longev. 2018:1.
   Google Scholar
• Mendis M, Leclerc E, Simsek S. 2016. Arabinoxylans, gut microbiota and immunity. Carbohydr Polym. 139:159–166.
   PubMed Web of Science ®Google Scholar
• Neyrinck AM, Possemiers S, Druart C, Van De Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM. 2011. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One. 6(6):e20944.
   PubMed Web of Science ®Google Scholar
• Niño-Medina G, Carvajal-Millán E, Rascon-Chu A, Marquez-Escalante JA, Guerrero V, Salas-Muñoz E. 2010. Feruloylated arabinoxylans and arabinoxylan gels: structure, sources and applications. Phytochem Rev. 9(1):111–120.
   Web of Science ®Google Scholar
• Nkamga VD, Henrissat B, Drancourt M. 2017. Archaea: essential inhabitants of the human digestive microbiota. Human Microbiome J. 3:1–8.
   Google Scholar
• Parks DH, Tyson GW, Hugenholtz P, Beiko RG. 2014. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 30(21):3123–3124.
   PubMed Web of Science ®Google Scholar
• Parnell JA, Reimer RA. 2012. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. Br J Nutr. 107(04):601–613.
   PubMedGoogle Scholar
• Paz-Samaniego R, Méndez-Encinas M, Fierro-Islas J, Marquez-Escalante J, Rascón-Chu A, Martinez-Lopez A, Carvajal-Millan E. 2014. Ferulated arabinoxylans recovered from low-value maize by-products: gelation and antioxidant capacity. In Benefits WB, editor. Ferulic acid: antioxidant properties, uses and potential health benefits. New York (NY): Nova Science Publisher, Inc; p. 151–164.
   Google Scholar
• Rattan O, Izydorczyk MS, Biliaderis CG. 1994. Structure and rheological behaviour of arabinoxylans from Canadian bread wheat flours. LWT-Food Sci Technol. 27(6):550–555.
   Google Scholar
• Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, et al. 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut. 61(4):543–553.
   PubMed Web of Science ®Google Scholar
• Snelders J, Olaerts H, Dornez E, Van De Wiele T, Aura A-M, Vanhaecke L, Delcour JA, Courtin CM. 2014. Structural features and feruloylation modulate the fermentability and evolution of antioxidant properties of arabinoxylanoligosaccharides during in vitro fermentation by human gut derived microbiota. J Funct Foods. 10:1–12.
   Web of Science ®Google Scholar
• Tremaroli V, Bäckhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature. 489(7415):242–249.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 3(4):213–223.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The human microbiome project. Nature. 449(7164):804.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122):1027–1031.
   PubMed Web of Science ®Google Scholar
• Turroni F, Ventura M, Buttó LF, Duranti S, O’toole PW, Motherway MOC, Van Sinderen D. 2014. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci. 71(2):183–203.
   PubMed Web of Science ®Google Scholar
• Wang YM, Wang WP, Wang LP, Lü QH, Zhou XH. 2010. Calorie control increased vaspin levels of serum and periepididymal adipose tissue in diet-induced obese rats in association with serum free fatty acid and tumor necrosis factor alpha. Chin Med J. 123:936–941.
   PubMed Web of Science ®Google Scholar
• Wu F, Guo X, Zhang J, Zhang M, Ou Z, Peng Y. 2017. Phascolarctobacterium faecium abundant colonization in human gastrointestinal tract. Exp Therap Med. 14(4):3122–3126.
   PubMed Web of Science ®Google Scholar
• Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, Alegado R, Dong B, Li D, Jia W. 2016. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget. 7(15):19355.
   PubMed Web of Science ®Google Scholar